Carbidopa / Levodopa Oral Suspension
- Brand(s)
- Duopa
- Category(s)
- prescription
- SPL Type(s)
- Human Prescription
- Master SPL
- Abbvie Inc. (2015-05-27)
- Oldest Current Product
- 2015-01-15
- License(s)
- NDA
- RxNORM
- ORAL SUSPENSION\CARBIDOPA:LEVODOPA
- FDAOB
- ENTERAL\SUSPENSION\CARBIDOPA: LEVODOPA
- SPL Active
- ENTERAL\SUSPENSION\CARBIDOPA: LEVODOPA
- SPL Moiety
- ENTERAL\SUSPENSION\CARBIDOPA ANHYDROUS: LEVODOPA
product(s) by strength(s)
carbidopa 4.63 mg/ml / levodopa 20 mg/ml oral suspension
# | id | title | applicant | approved | exclusivity | approved drug |
---|
1 | NDA203952 | DUOPA | ABBVIE INC | 2015-01-09 | ORPHAN DRUG EXCLUSIVITY [2022-01-09] NEW PRODUCT [2018-01-09] | NDA203952_001 |
# | id | category/deprecated | ingredient strength(s) | route | dose form | rld | approved | application |
---|
1 | NDA203952_001 | RX | LEVODOPA (20MG/ML), CARBIDOPA (4.63MG/ML) | ENTERAL | SUSPENSION | True | 2015-01-09 | DUOPA |
# | id | title | category | type | labeler | last update | version | product(s) |
---|
1 | 7066d371-dc6a-0d6f-7bed-e5dd4ee912da (view SPL) | These highlights do not include all the information needed to use DUOPA safely and effectively. See full prescribing information for DUOPA. DUOPA (carbidopa and levodopa) enteral suspension Initial U.S. Approval: 1975 | prescription | Human Prescription | Abbvie Inc. | 2015-05-27 | 119 | 000743012 |